Type-1 Diabetes Treatment Market Forecast 2021 Share, Production, Revenue

Posted by vinit sawant on February 3rd, 2021

According to Market Research Future (MRFR), the global type-1 diabetes treatment market is expected to cross USD 9.6 billion, with a CAGR of 7.9%. from 2019 to 2025 (forecast period).

The body requires insulin hormone to get glucose from the bloodstream to the cells to generate energy. Most forms of diabetes can be categorized as type 1a - Autoimmune disease, where the breakdown of pancreatic beta cells is observed, low insulin production disrupts blood glucose homeostasis, and mild cases of type 1b - Idiopathic Diabetes Mellitus. This type of diabetes is rare and occurs during childhood or adolescence, but can also be seen in adults.

Market Dynamics

The global market for type 1 diabetes is expected to grow significantly over the forecast period due to the rising prevalence of type-1 diabetes due to environmental and genetic factors. Unhealthy eating habits, growing geriatric population, increasing obesity, and sedentary lifestyles are the main contributors to the growth of the global type 1 diabetes industry. Governmental initiatives to control diabetes and the economic impact of the disease on health systems in several countries are expected to propel the market growth.

Whereas, intense reimbursement policies, adverse side effects of the medication, and high diagnosis and treatment costs are constraining factors for the growth of the global type 1 diabetes treatment market.

Segmentation

Based on the product, the global market for type-1 diabetes treatment has been segmented into rapid-acting insulin, short-acting insulin, medium-acting insulin, long-acting insulin, and others. Rapid-acting insulin is the largest and fastest-growing market in this segment.